MolecuLight
Moleculight is developing a non-invasive optical technology that acquires images like standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry-standard wound assessment techniques, including conventional white light visualization. The first application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing a rapid and accurate diagnosis.
Moleculight is developing a non-invasive optical technology that acquires images like standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry-standard wound assessment techniques, including conventional white light visualization. The first application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing a rapid and accurate diagnosis.
MolecuLight has raised $46.0M across 4 rounds. Its most recent round was a Series Unknown of $27.5M in Jan 2025. Full funding history, investors, and team are detailed below.
Funding history
4 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 3 earlier rounds — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
MolecuLight is featured in
Similar companies
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to improve airway management.
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds. The research formulations and extraction methods investigate molecular discovery with restricted psychedelic compounds. The company produces scalable, natural mushroom formulations and other psychedelics.
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous.
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people, ideas and resources.
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental health across all Canadian provinces and territories.
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food industries.
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They also provide telehealth services for the diagnostic imaging and radiology sectors.
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality mushroom health supplements. The company creates organic and medicinal mushrooms for general body wellness. It protects, restores, and regain a healthier body and mind through the production and distribution of artisanal, medicinal mushrooms. Psyched Wellness is based in Toronto, Ontario, Canada.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.